MedTrace Logo

Pico-Salax Colonic Preparation Study: Quantifying Electrolyte and Volume Status Changes

NCT00885430 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-09-22

No results posted yet for this study

Summary

Twenty adult volunteers will be administered Pico-Salax in the usual fashion for colonoscopy with intense monitoring of serum and urine chemistry and hemodynamics.

Conditions

Interventions

DRUG

Pico-Salax

Two sachets of Pico-Salax given 5 hours apart

Sponsors & Collaborators

  • Ferring Pharmaceuticals

    collaborator INDUSTRY

  • Queen's University

    lead OTHER

Principal Investigators

  • Lawrence Hookey, MD · Queen's University

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2008-07-31
Completion
2008-09-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00885430 on ClinicalTrials.gov